Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Charles L. Loprinzi(Mayo Clinic in Arizona), Dawn L. Hershman(Columbia University), Jonathan Bleeker(Sanford Health), Nina D. Wagner‐Johnston(Sidney Kimmel Comprehensive Cancer Center), Mary Lou Smith(Research Advocacy Network), Christina Lacchetti(Washington Hospital), Elizabeth Smith(National Jewish Health), Thomas J. Smith(Sidney Kimmel Cancer Center), Mark R. Kelley(University of Indianapolis), Daniel L. Hertz(GTx (United States)), Antoinette Lavino(American Society of Clinical Oncology), Guido Cavaletti(Bellvitge University Hospital), Maryam B. Lustberg(Yale Cancer Center), Judith A. Paice(Northwestern University), Cynthia Chauhan(American Society of Clinical Oncology), Bryan P. Schneider(Shanghai University of Traditional Chinese Medicine)
Cited by 1,090
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k